Solvent recycler drives sustainability in pharma labs
The SPR-200 Solvent Recycler (courtesy: Biotech Fluidics)

HPLC

Solvent recycler drives sustainability in pharma labs

16 Dec, 2024

Biotech Fluidics has announced that a leading pharmaceutical company has invested in 17 SPR-200 solvent recycler units to enhance the sustainable use of solvents in HPLC systems across its analytical laboratories.

The SPR-200 operates as a standalone, externally powered unit, eliminating the need for an external computer and avoiding potential connectivity challenges with IT systems.

Designed for compatibility with most HPLC systems, the SPR-200 continuously monitors detector output signals during liquid chromatography. In customer laboratories, it has demonstrated the ability to recover up to 90% of the mobile phase by redirecting purified solvent into a dedicated reservoir during isocratic HPLC.

Fritiof Ponten, CEO of Biotech Fluidics, commented: “Controlled via an integral LED screen and membrane keyboard – the SPR-200’s user-friendly software allows you to configure operational parameters and to perform online monitoring and create an audit trail of recovered solvent.”

He added: “Not only does the SPR-200 improve sustainability in your lab, but it also quickly pays for itself by enabling you to recycle nearly all the solvent used in your isocratic HPLC systems.”

More information online

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Highly sophisticated sensor technology elevates gas detection solutions to enhance safety in underground car parks and battery energy storage systems
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
Tunable infrared chip could sharpen gas leak and pollution detection
Explore more Arrow
Chromatography Today
SLAS Technology Volume 38 highlights AI-driven laboratory automation, transcriptomics and gene therapy
Explore more Arrow